Morgan Jess S & CO Inc Clene Inc. Transaction History

Morgan Jess S & CO Inc

  • $115 Million
  • Q3 2022

A detailed history of Morgan Jess S & CO Inc transactions in Clene Inc. stock. As of the latest transaction made, Morgan Jess S & CO Inc holds 112,000 shares of CLNN stock, worth $560,000. This represents 0.27% of its overall portfolio holdings.

Number of Shares
112,000
Previous 87,250 28.37%
Holding current value
$560,000
Previous $220,000 42.73%
% of portfolio
0.27%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 21, 2022
BUY
$0.33 - $73.0 $8,167 - $1.81 Million
24,750 Added 28.37%
112,000 $314,000
Q1 2022

May 16, 2022
BUY
$2.42 - $4.42 $139,150 - $254,150
57,500 Added 193.28%
87,250 $344,000
Q3 2021

Nov 09, 2021
BUY
$6.83 - $13.58 $203,192 - $404,005
29,750 New
29,750 $203,000

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $318M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Morgan Jess S & CO Inc Portfolio

Follow Morgan Jess S & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Jess S & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Jess S & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email